Dacomitinib Intermediate 2 NEW

$41.00 5mg

$58.00 10mg

$93.00 25mg

Min. Order
Purity99.27%
Cas No179552-74-0
Supply Ability10g
Update time2024-11-19

TargetMol Chemicals Inc.

5YR

United States

Since2011-01-07

Address36 Washington Street, Wellesley Hills

show less show more

Chemical Properties

Product Name	Dacomitinib Intermediate 2
CAS No	179552-74-0
EC-No
Min. Order
Purity	99.27%
Supply Ability	10g
Release date	2024/11/19

Product Introduction

Bioactivity

Name	Dacomitinib Intermediate 2
Description	Dacomitinib Intermediate 2 (N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-nitroquinazolin-4-amine) has anticancer activity and can be used to study lung cancer.
Storage	Shipping with blue ice.
Solubility Information	DMSO : 16.67 mg/mL (47.79 mM), Sonication is recommended.
Related Compound Libraries	Bioactive Compound Library \| Bioactive Compounds Library Max

show less show more

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.